Introduction
Liver transplantation has become the standard of care for the treatment of a variety of liver diseases that in the past would have resulted in an early death. According to the United Network for Organ Sharing (UNOS) there are currently 14,433 candidates waiting for a liver transplant in the United States. A total of 7,841 liver transplants were performed in the United States in 2016 [1] . Despite increased education regarding organ donation and advances in patient management, there continues to be a gap in the supply and demand of organs for transplant. Due to this scarce resource, pre and post-transplant patient management remains a key focus in achieving optimal outcomes. Transplant medicine is a highly complex, specialized field, requiring specialized knowledge and management of the patient in the pre-transplant phase and the early post -transplant period. Patients requiring a liver transplant often are managed in the outpatient setting but can require intensive care placement for acute liver failure or decompensated end stage liver disease (ESLD). Critical care nurses play a role in the care of these patients. The best patient outcomes occur when expertise and experience coincide [2] . The purpose of this article is to provide critical care nurses with an overview of liver disease and transplantation for adult patients with a diagnosis of liver failure.
(S)Overview of Liver Function
The liver is the largest internal organ in the human body. Weighing an average of 3 pounds in the average adult, it performs more than 500 critical functions (REF) . At any time, it holds one quarter of the body's blood supply, and filters 1.4 liters of blood per minute and is responsible for 25% of the cardiac output. The portal vein supplies 75% of the liver's blood flow, and the remaining 25% of blood supply to the liver comes from the hepatic artery. Substances transported tothe liver may be metabolized, stored, modified, or detoxified and then released into the circulation or intestine to be excreted. The liver plays a vital role in fat metabolism, gluconeogenesis, and the metabolism of carbohydrates. It is an important metabolizer of proteins, converting amino acids from foods to produce energy, fats, or carbohydrates. The byproduct of this energy conversion is ammonia, which the liver converts to urea which is released into the blood, transported to the kidneys, and finally removed from the body in urine. The liver synthesizes several clotting factors, II, VII, IX, X, as well as factor V and factor XI (Northrup, Caldwell). It plays a primary role in gluconeogenesis and regulates blood glucose levels and produces approximately one liter of bile per day. Bile is vital for the absorption of fat-soluble vitamins and elimination of toxic substances.
The liver is the primary site for metabolism of medications through enzymes within the Cytochrome P450 (CYP 450) pathways. Drugs that affect these pathways are referred to as either inhibitors or inducers; those that cause increased concentrations of other drugs that utilize this pathway are inhibitors and can lead to subtherapeutic drug levels. Conversely, drugs that cause 
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(S)Indications for Liver Transplant
The need for liver transplant is considered when a patient with cirrhosis has signs and symptoms 
Acute Hepatic Failure
In the Intensive Care Unit (ICU) patients awaiting liver transplant typically have been admitted in acute or "fulminant" hepatic failure (AHF). This is defined as "hepatic 
Liver Transplant Evaluation
Patients with acute fulminant liver failure (AFLF) or end stage liver disease (ESLD) experience the sequelae of liver disease, often requiring admission to the intensive care unit ( ICU ) for medical management. Chronic and acute liver failure patients are considered candidates for liver transplantation, now a treatment modality to decrease patient death. Intensive, supportive critical care patient management and liver transplantation provides an opportunity for patient survival for the majority of patients with acute fulminant liver failure [3] . The one year survival rate for patients with a primary (first) liver transplant is 91.8%. [1] . Currently there are approximately 170 transplant centers in the United States [1] . Patients referred for transplantation will be seen and evaluated at a transplant center by the transplant team. The ICU nurse can work with the transplant team to provide psychological support and education to the patient and family during the evaluation process.
Transplant centers provide the expertise of a multidisciplinary transplant team approach to the evaluation process. The patient undergoes both physical and psychological testing to determine readiness for transplantation and the required long term care post-transplant care. The transplant evaluation is described as a 3-fold process with goals of establishing a diagnosis of ESLD;
excluding any absolute or relative contraindications to transplant; and determining the suitability and degree of patient illness to better allocate resources and optimize survival [4] . The transplant evaluation process may vary from center to center with patient specific diagnostic testing being required. Patient disease and illness severity plays a key role in organ allocation and patient listing for transplant. Scoring systems are specified according to age with The Model for End-Stage Liver Disease (MELD) used for patients 12 years and older. The MELD calculator provides a scoring system to determine how urgently a patient will need a liver transplant within the next three months [1] . The MELD calculates a patient's score based on the following laboratory tests: serum creatinine (mg/dl), bilirubin(mg/dl), INR, and serum sodium (mEq/L). The serum sodium, especially a low sodium level, is variable associated with mortality, independent of the MELD score and has recently been added to the MELD calculator [8] . Kidney function is also assessed through the question: has the patient had dialysis twice within the last week, or 24 hours of CVVHD? If yes, the creatinine value is automatically registered at 4 mg/dl. Often patients in the ICU setting are requiring dialysis or CVVHD. The MELD calculation determines organ allocation based on the patient's score and geographic location. Scores range from 6 to 40 with a higher score indicating a sicker patient. An exception to this rule are patients that receive MELD exception points based on certain diagnoses such as hepatocellular carcinoma and portopulmonary hypertension to account for a higher waitlist mortality not reflected in the MELD score [9] .
In 2013 the Share 35 policy was approved by UNOS mandating regional sharing of livers throughout 11 UNOS regions for patients with a MELD of 35 or greater. The Share 15 policy provides patients with a MELD of 15 or greater offers from the local organ procurement organization (OPO) first and then regionally Critically ill patients in the ICU setting with a life expectancy of seven days or less qualify for a status IA on the UNOS list.
Status IA organ offers can be from the local, regional or national UNOS list. If the patient's condition worsens and the patient becomes temporarily too unstable to undergo a liver transplant, the patient's status is changed to a status 7. Status 7 makes the patient inactive on the transplant list until stabilization is achieved and the status is updated. Status The patient's blood type and size are also required for UNOS listing with organ acceptance dependent on donor-patient size similarity and blood type compatibility. [11] . When a suitable organ is found for the patient, the liver transplant is performed and the patient returns to the ICU for post-transplant management. It is important for ICU nurses to be familiar with potential complications that can occur, often requiring immediate
intervention. Early Post-Transplant Complications
Complications occurring post liver transplant can be categorized into early and late complications. For the purpose of this article, focus will be on the early post-transplant complications. Use of extended criteria donors (ECD) can increase the risk of less than optimal patient outcomes, including early complications. Donor variables known to affect patient outcomes include increased age, long hospitalization, extended warm or cold ischemic times and donor liver steatosis, leading to reperfusion syndrome, ischemia and graft dysfunction [12, 7] .
Primary Graft non-function(PGNF)
Complete graft failure immediately post-transplant without a definitive cause has been defined as primary non-function. This type of liver injury can result in severe liver dysfunction with elevation in liver enzymes immediately post-transplant, secondary organ damage due to the liver dysfunction, biliary strictures and even re-transplant. Patients exhibit symptoms of comma, coagulopathy, oliguria, hypoglycemia and marked elevation in liver function tests with transaminases often greater than 5000 U/L [7] . The critical care nurse must be aware of these signs and symptoms of liver dysfunction and alert the transplant team.
Early Acute Cellular Rejection
Early acute cellular rejection usually occurs within the first 90 days post liver transplant while chronic rejection can occur later post-transplant, and is usually a result of low immunosuppression levels. Acute cellular rejection is usually reversible but chronic rejection can affect long term graft and patient survival. Symptoms of acute rejection can include elevated LFTs (serum aminotransferases, alkaline phosphatase, gamma-glutamyl transpeptidase (GGT), and bilirubin levels), fever, abdominal pain and malaise. The gold standard to diagnose rejection is liver biopsy, percutaneous or transjugular. Treatment for rejection includes high dose corticosteroids, and an increase in immunosuppressant dosing or adding a second agent.
Patients transplanted for HCV may be treated without the addition of steroids due to the impact on HCV progression. HCV and rejection have similar histological markers, often making diagnosis difficult to differentiate. Patients transplanted with a diagnosis of autoimmune hepatitis may require a more aggressive approach to the treatment of rejection, including high dose steroids. It is important to differentiate rejection from infection in the early post liver transplant patient to ensure appropriate treatment.
Vascular Complications
Hepatic Artery Thrombosis
Hepatic Artery Thrombosis (HAT) has been estimated to occur in 4-12% of adult liver transplants with causes including hepatic artery narrowing, kinking or a mismatch with the donor-recipient vessels [13] . Hepatic artery thrombosis is diagnosed through Doppler ultrasonography. Re-transplantation is indicated if blood flow cannot be restored to the transplanted graft.
Portal Vein Thrombosis
Portal Vein Thrombosis(PVT) occurs in approximately 1-13% of liver transplant recipients and can be the result of technical problems during the time of surgery, thrombus formation, or a hypercoagulable state [13] . A PVT can be diagnoses through ultrasonography showing an increase in velocity within the portal vein; CT scanning; an MRI or magnetic resonance venography (MRV). Treatment may include a thrombectomy, transjugular intrahepatic portosystemic shunt (TIPS) or re-transplant.
Biliary Complications
Liver transplantation requires biliary reconstruction, connecting the common hepatic duct of the donor to the native bile duct of the recipient(choledocho-choledochostomy) or connection of the donor common bile duct to a portion of the recipient's jejunum ( Roux-en-Y choledochojejunostomy). The type of biliary reconstruction is determined by surgeon preference, underlying liver disease, donor and recipient bile duct size or previous surgeries [14] .
Use of a temporary biliary stent for an end-to-end biliary connection is also determined by transplant surgeon preference. Depending on stent placement technique, the stent may be passed through the GI track or require removal through an endoscopic retrograde cholangiopancreatography (ERCP) around three month post-transplant. The stent is radiopaque with placement or migration can be confirmed on abdominal x-ray.
Approximately 13-19% of adults receiving a deceased donor liver transplant can have biliary complications [13] Biliary complications include biliary strictures and bile leaks.
Biliary Leaks and Strictures
The ICU nurse will be more concerned about biliary leaks in the immediate post operative Table   2 . 
Renal Dysfunction
Hypovolemia during and early post operatively along with high levels of immunosuppressant agents with known renal toxicity can cause worsening of kidney function. It is important for the ICU nurse to monitor the patient's renal function and urine output, observing for worsening function, indicating the need for dialysis. Immunosuppression will need to be modified in the picture of worsening kidney function due to the nephrotoxic effects of the calcineurin inhibitors ( Cyclosporine and Tacrolimus).
Additional Complications
Post-operative nursing management includes patient assessment for bleeding, wound infection or 
Immunosuppression
Common immunosuppressant agents are listed in Table 3 . Transplant centers have specific protocols for immunosuppression dosing, monitoring and therapeutic drug levels related to post transplant time periods. 
